CIN 3

4 registered clinical trials studyying CIN 3 — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Pop NCT07211204	Timser SAPI de CV	N/A
Recruiting	Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Year NCT04895020	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Completed	Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101	Shanghai Bovax Biotechnology Co., Ltd.	Phase 1
Completed	Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women NCT01366742	University of California, Los Angeles	—